Two top cancer experts have been named to lead Mount Sinai’s new Tisch Cancer Hospital, which is under development and due to open in 2027. Cardinale B. Smith, MD, PhD, has been appointed Chief Medical Officer for the Tisch Cancer Hospital and Vice President of Cancer Clinical Affairs, and Ash Tewari, MBBS, MCh, has been appointed Surgeon-in-Chief of the Tisch Cancer Hospital.
The Tisch Cancer Hospital will be a state-of-the-art cancer facility at The Mount Sinai Hospital, thanks to a generous $60 million gift from James S. and Merryl H. Tisch. Under the leadership of Dr. Smith and Dr. Tewari, the Hospital, which is part of the Tisch Cancer Center launched last year, will transform oncologic care, expand access to life-saving breakthroughs, and promote Mount Sinai as a leader in cancer treatment and research.
The new Tisch Cancer Hospital is really giving us the opportunity to reimagine what cancer care is, how we deliver it. What it looks like, how we provide that to patients, the environment that we're able to create for them really throughout their journey, from start to finish, can we take care of cancer better? Can we minimize the side effect on the patient? Can we give a better quality of life? And can we still understand why this cancer happens? We're really already really great cancer center, but the new cancer hospital is really gonna put us on a new plateau where we'll be able to offer our thousands of patients that we have every year, the specialty care they need when they need to be hospitalized. When we think about some of the newer treatments that are being rolled out like immune effect or cell therapies. This is the next phase in how we are going to be able to both treat and improve prognosis and how well people with cancer are able to respond to therapies. Many of these treatments do have significant side effects. And right now, we have to be able to manage those patients in the inpatient setting. This is really where having a new cancer hospital will be able to take much of the leading research that's happening right here with us at Mount Sinai and be able to apply that to delivery of cancer care on the inpatient setting, New York needs and fully integrated cancer hospital. Within a whole network of healthcare. We are already one of the largest healthcare network in this part of the world. And our expertise is in taking care of disease and patients. Mount Sinai Tisch Cancer Hospital will be a hospital within the hospital supported by an expert of all subspecialties supported by best cardiologist, best endocrinologist, best person taking care of the transplants, best nephrologist and that is what will differentiate the cancer care because cancer doesn't comes in isolation. When we designed the cancer hospital, we did it with the mindset of thinking about the modern concept of what a hospital looks like today. As opposed to 40 years ago, our realization was that for our cancer patients to have the level of care and world class facilities, we needed to have a dedicated cancer hospital which will make the cancer journey a much more convenient and hold so for our patients, how can we accommodate the the whole journey all the way from ICU level care to palliative care within the same environment? And more than anything else, we need to recognize the fact that the cancer journey for the patient requires caregivers. How can we accommodate caregivers within the environment of the hospital? The vision by Mount Sinai to create the Tisch Cancer Hospital was bold. It was visionary. We needed exceptional leadership that would help us in realizing our aspirations to provide exceptional cancer care for our patients. Doctors, Tiwari and Smith are those leaders. This is clearly a moment of hope for cancer patients and their families.
